Czechia· CZ-0243200

BUSCOPAN

A butylscopolamine product containing hyoscine butylbromide, registered in Czechia by Mayoly Pharma France, Rueil-Malmaison. The same ATC class is registered in 11 of our 19 countries.

ATC A03BB01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedBUSCOPANATCA03BB01REGISTER NO.CZ-0243200PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Butylscopolamine is registered in 11 of 19 countries.

Countries holding a registration under ATC A03BB01 (butylscopolamine), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 6 of them publish a price we can compare per daily dose

Butylscopolamine · ATC A03BB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
HYOSCINE BUTYLBROMIDE
Manufacturer
Mayoly Pharma France, Rueil-Malmaison
Country
Czechia (CZ)
ATC code
A03BB01
ATC class
Butylscopolamine
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Butylscopolamine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All butylscopolamine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Buscapina, Buscopan
  • Belgium · Buscopan, Buscopan Forte
  • Bulgaria · Бусколизин, Бусколизин Форте
  • Cyprus · Avotrin, Buscopan
  • Germany · Buscopan, Buscopan Ampullen
  • Denmark · Bumacor
  • Estonia · Bysimin
  • Spain · Buscapina, Buscopresc
  • Finland · Bumacor, Buscopan
  • France · Buscopan, Scoburen
  • United Kingdom (Northern Ireland) · Almus Ibs Relief, Almus Stomach Cramp Relief
  • Greece · Avotrin, Buscopan
  • Croatia · Buscopan, Bysimin
  • Hungary · Buscopan, Buscopan Forte
  • Ireland · Buscopan, Buscopan Ampoules
  • Italy · Addofix, Buscopan
  • Luxembourg · Buscopan, Buscopan Forte
  • Latvia · Buscopan, Hyoscine Butylbromide Kalceks
  • Malta · Buscopan, Buscopan Ampoules
  • Netherlands · Buscopan, Scopolamine Butylbromide Kalceks
  • Norway · Bumacor, Buscopan
  • Poland · Aurogastro, Buscolysin
  • Portugal · Buscopan, Butilescopolamina Conforpam
  • Romania · Buscopan, Buscotil
  • Sweden · Bumacor, Buscopan
  • Slovenia · Buscopan
  • Slovakia · Buscopan, Scopolamine Butylbromide Kalceks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fcf2a94d-6c8d-4a1e-8e6f-e3472a8ab44a
GET /v1/drugs/fcf2a94d-6c8d-4a1e-8e6f-e3472a8ab44a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL OBD",
  "source": "sukl",
  "strength": "10MG",
  "pack_size": "10",
  "substance": "HYOSCINE BUTYLBROMIDE",
  "cz_kod_sukl": "0243200",
  "product_type": "CH",
  "substance_codes": "753",
  "registration_state": "R",
  "registration_number": "73/311/70-S/C"
}

See everything about butylscopolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.